Neumora Therapeutics, Inc. (NMRA)

1.87 -0.15 (-7.43%) USD  |  NASDAQ  |  Jan 20, 16:00
1.91 +0.04 (+2.14%) Pre-Market: 09:21
More

Neumora Therapeutics Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for NMRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Ventyx Biosciences, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
Nautilus Biotechnology, Inc. Upgrade
ProKidney Corp. Upgrade
MapLight Therapeutics, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade